Header Logo

Connection

Mark Pollack to Adult

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Adult.
Mark Pollack
Connection Strength
3.442
Adult
  1. "I knew it was wrong the moment I got the order": A narrative thematic analysis of moral injury in combat veterans. Psychol Trauma. 2019 May; 11(4):396-405.
    View in: PubMed
    Score: 0.065
  2. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255.
    View in: PubMed
    Score: 0.064
  3. Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD. Brain Behav. 2015 Feb; 5(2):e00304.
    View in: PubMed
    Score: 0.052
  4. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):402-11.
    View in: PubMed
    Score: 0.051
  5. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
    View in: PubMed
    Score: 0.048
  6. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety. 2013 Nov; 30(11):1114-20.
    View in: PubMed
    Score: 0.047
  7. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. J Consult Clin Psychol. 2013 Dec; 81(6):1100-12.
    View in: PubMed
    Score: 0.047
  8. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry. 2013 Jul; 170(7):751-8.
    View in: PubMed
    Score: 0.047
  9. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
    View in: PubMed
    Score: 0.042
  10. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Jul; 72(7):892-7.
    View in: PubMed
    Score: 0.040
  11. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr; 49(4):275-80.
    View in: PubMed
    Score: 0.039
  12. Khy?l attacks: a key idiom of distress among traumatized cambodia refugees. Cult Med Psychiatry. 2010 Jun; 34(2):244-78.
    View in: PubMed
    Score: 0.038
  13. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
    View in: PubMed
    Score: 0.037
  14. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
    View in: PubMed
    Score: 0.036
  15. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010 Feb 15; 67(4):365-70.
    View in: PubMed
    Score: 0.036
  16. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry. 2009 Nov; 70(11):1563-70.
    View in: PubMed
    Score: 0.036
  17. Nightmares among Cambodian refugees: the breaching of concentric ontological security. Cult Med Psychiatry. 2009 Jun; 33(2):219-65.
    View in: PubMed
    Score: 0.035
  18. Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34.
    View in: PubMed
    Score: 0.034
  19. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23.
    View in: PubMed
    Score: 0.034
  20. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
    View in: PubMed
    Score: 0.033
  21. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
    View in: PubMed
    Score: 0.033
  22. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84.
    View in: PubMed
    Score: 0.032
  23. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
    View in: PubMed
    Score: 0.032
  24. Orthostatic panic attacks among Vietnamese refugees. Transcult Psychiatry. 2007 Dec; 44(4):515-44.
    View in: PubMed
    Score: 0.032
  25. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 01; 32(3):739-43.
    View in: PubMed
    Score: 0.032
  26. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3.
    View in: PubMed
    Score: 0.031
  27. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
    View in: PubMed
    Score: 0.031
  28. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Med Anthropol Q. 2007 Mar; 21(1):81-107.
    View in: PubMed
    Score: 0.030
  29. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb; 27(1):85-8.
    View in: PubMed
    Score: 0.030
  30. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007; 24(1):1-14.
    View in: PubMed
    Score: 0.030
  31. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64.
    View in: PubMed
    Score: 0.029
  32. An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
    View in: PubMed
    Score: 0.028
  33. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9.
    View in: PubMed
    Score: 0.028
  34. Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Depress Anxiety. 2006; 23(2):113-5.
    View in: PubMed
    Score: 0.028
  35. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38.
    View in: PubMed
    Score: 0.028
  36. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress Anxiety. 2006; 23(6):373-6.
    View in: PubMed
    Score: 0.028
  37. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8.
    View in: PubMed
    Score: 0.027
  38. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5.
    View in: PubMed
    Score: 0.027
  39. Rates of isolated sleep paralysis in outpatients with anxiety disorders. J Anxiety Disord. 2006; 20(5):687-93.
    View in: PubMed
    Score: 0.027
  40. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005 Jul-Aug; 46(4):334-9.
    View in: PubMed
    Score: 0.027
  41. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11.
    View in: PubMed
    Score: 0.026
  42. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004 Dec; 161(12):2222-9.
    View in: PubMed
    Score: 0.026
  43. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct; 17(5):429-33.
    View in: PubMed
    Score: 0.025
  44. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry. 2004 Sep; 65(9):1219-22.
    View in: PubMed
    Score: 0.025
  45. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5.
    View in: PubMed
    Score: 0.025
  46. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99.
    View in: PubMed
    Score: 0.025
  47. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003 Nov; 41(11):1271-6.
    View in: PubMed
    Score: 0.024
  48. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
    View in: PubMed
    Score: 0.024
  49. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):17-30.
    View in: PubMed
    Score: 0.023
  50. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. J Clin Psychopharmacol. 2003 Jun; 23(3):250-9.
    View in: PubMed
    Score: 0.023
  51. Relationship between adult social phobia and childhood anxiety. Braz J Psychiatry. 2003 Jun; 25(2):96-9.
    View in: PubMed
    Score: 0.023
  52. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003 May-Jun; 44(3):222-36.
    View in: PubMed
    Score: 0.023
  53. Bupropion sustained release for panic disorder. Psychopharmacol Bull. 2003; 37(4):66-72.
    View in: PubMed
    Score: 0.022
  54. A novel cognitive-behavioral approach for treatment-resistant drug dependence. J Subst Abuse Treat. 2002 Dec; 23(4):335-42.
    View in: PubMed
    Score: 0.022
  55. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis. 2002 Jul; 190(7):453-6.
    View in: PubMed
    Score: 0.022
  56. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8.
    View in: PubMed
    Score: 0.021
  57. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord. 2002 May; 69(1-3):209-17.
    View in: PubMed
    Score: 0.021
  58. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190.
    View in: PubMed
    Score: 0.020
  59. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001 May; 62(5):350-7.
    View in: PubMed
    Score: 0.020
  60. Prevalence of childhood ADHD among patients with Generalized Anxiety Disorder and a comparison condition, Social Phobia. Depress Anxiety. 2001; 13(4):190-1.
    View in: PubMed
    Score: 0.020
  61. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777.
    View in: PubMed
    Score: 0.019
  62. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect Immun. 2000 Mar; 68(3):1655-63.
    View in: PubMed
    Score: 0.018
  63. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463.
    View in: PubMed
    Score: 0.018
  64. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729.
    View in: PubMed
    Score: 0.018
  65. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.018
  66. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychol Trauma. 2020 May; 12(4):422-430.
    View in: PubMed
    Score: 0.018
  67. Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999 Jul; 187(7):429-34.
    View in: PubMed
    Score: 0.018
  68. Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607.
    View in: PubMed
    Score: 0.017
  69. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 07; 36(7):617-624.
    View in: PubMed
    Score: 0.017
  70. An Open Trial of Morning Bright Light Treatment Among US Military Veterans with Chronic Low Back Pain: A Pilot Study. Pain Med. 2019 04 01; 20(4):770-778.
    View in: PubMed
    Score: 0.017
  71. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998 Nov; 55(11):1010-6.
    View in: PubMed
    Score: 0.017
  72. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242.
    View in: PubMed
    Score: 0.017
  73. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
    View in: PubMed
    Score: 0.016
  74. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998 Jul-Aug; 36(7-8):665-73.
    View in: PubMed
    Score: 0.016
  75. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40.
    View in: PubMed
    Score: 0.016
  76. Negative posttraumatic cognitions among military sexual trauma survivors. J Affect Disord. 2018 10 01; 238:88-93.
    View in: PubMed
    Score: 0.016
  77. Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry Hum Dev. 2018 04; 49(2):209-216.
    View in: PubMed
    Score: 0.016
  78. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78.
    View in: PubMed
    Score: 0.016
  79. Nefazodone for social phobia: a clinical case series. Depress Anxiety. 1998; 8(3):131-3.
    View in: PubMed
    Score: 0.016
  80. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
    View in: PubMed
    Score: 0.016
  81. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? J Anxiety Disord. 2018 01; 53:85-90.
    View in: PubMed
    Score: 0.016
  82. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. J Trauma Stress. 2017 12; 30(6):698-703.
    View in: PubMed
    Score: 0.016
  83. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. J Immunol. 1997 Oct 01; 159(7):3519-30.
    View in: PubMed
    Score: 0.016
  84. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997 Sep-Oct; 11(5):499-502.
    View in: PubMed
    Score: 0.016
  85. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359.
    View in: PubMed
    Score: 0.015
  86. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behav Res Ther. 1997 Jun; 35(6):543-9.
    View in: PubMed
    Score: 0.015
  87. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 04; 262:328-332.
    View in: PubMed
    Score: 0.015
  88. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. J Psychosom Res. 2017 04; 95:7-11.
    View in: PubMed
    Score: 0.015
  89. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. J Clin Psychiatry. 1997; 58 Suppl 11:19-23.
    View in: PubMed
    Score: 0.015
  90. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996 Nov 25; 41(2):135-9.
    View in: PubMed
    Score: 0.015
  91. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45.
    View in: PubMed
    Score: 0.014
  92. Treatment of dysphoric mania with nefazodone. Am J Psychiatry. 1996 May; 153(5):732-3.
    View in: PubMed
    Score: 0.014
  93. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72.
    View in: PubMed
    Score: 0.014
  94. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Behav Res Ther. 2016 06; 81:21-34.
    View in: PubMed
    Score: 0.014
  95. Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. Am J Psychiatry. 1996 Mar; 153(3):376-81.
    View in: PubMed
    Score: 0.014
  96. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull. 1996; 32(4):667-70.
    View in: PubMed
    Score: 0.014
  97. The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am. 1995 Dec; 18(4):785-801.
    View in: PubMed
    Score: 0.014
  98. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89.
    View in: PubMed
    Score: 0.014
  99. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5.
    View in: PubMed
    Score: 0.013
  100. Altered resting-state functional connectivity of the frontal-striatal reward system in social anxiety disorder. PLoS One. 2015; 10(4):e0125286.
    View in: PubMed
    Score: 0.013
  101. Integrated treatment of panic disorder. Bull Menninger Clin. 1995; 59(2 Suppl A):A4-26.
    View in: PubMed
    Score: 0.013
  102. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
    View in: PubMed
    Score: 0.012
  103. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
    View in: PubMed
    Score: 0.012
  104. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry. 2014 Dec 01; 76(11):902-10.
    View in: PubMed
    Score: 0.012
  105. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behav Ther. 2014 Sep; 45(5):619-29.
    View in: PubMed
    Score: 0.012
  106. Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology. 2014 May; 39(6):1340-6.
    View in: PubMed
    Score: 0.012
  107. Smiles may go unseen in generalized social anxiety disorder: evidence from binocular rivalry for reduced visual consciousness of positive facial expressions. J Anxiety Disord. 2013 Oct; 27(7):619-26.
    View in: PubMed
    Score: 0.012
  108. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63.
    View in: PubMed
    Score: 0.012
  109. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92.
    View in: PubMed
    Score: 0.012
  110. Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia. Depress Anxiety. 2014 Feb; 31(2):150-9.
    View in: PubMed
    Score: 0.012
  111. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. J Psychiatr Res. 2013 Oct; 47(10):1455-61.
    View in: PubMed
    Score: 0.012
  112. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56.
    View in: PubMed
    Score: 0.012
  113. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behav Ther. 2013 Dec; 44(4):651-61.
    View in: PubMed
    Score: 0.012
  114. Voxel-based morphometric gray matter correlates of posttraumatic stress disorder. J Anxiety Disord. 2013 May; 27(4):413-9.
    View in: PubMed
    Score: 0.011
  115. Loving-Kindness Meditation practice associated with longer telomeres in women. Brain Behav Immun. 2013 Aug; 32:159-63.
    View in: PubMed
    Score: 0.011
  116. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 01; 73(11):1054-8.
    View in: PubMed
    Score: 0.011
  117. Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry. 2013 Jan; 70(1):87-97.
    View in: PubMed
    Score: 0.011
  118. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. Am J Addict. 2013 Jan; 22(1):18-22.
    View in: PubMed
    Score: 0.011
  119. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res. 2013 Feb; 47(2):168-74.
    View in: PubMed
    Score: 0.011
  120. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depress Anxiety. 2012 Nov; 29(11):924-30.
    View in: PubMed
    Score: 0.011
  121. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. J Psychoactive Drugs. 2012 Jul-Aug; 44(3):237-42.
    View in: PubMed
    Score: 0.011
  122. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? J Anxiety Disord. 2012 Aug; 26(6):665-72.
    View in: PubMed
    Score: 0.011
  123. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83.
    View in: PubMed
    Score: 0.011
  124. Anchoring the Panic Disorder Severity Scale. Assessment. 2012 Jun; 19(2):257-9.
    View in: PubMed
    Score: 0.011
  125. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. J Anxiety Disord. 2012 Apr; 26(3):435-41.
    View in: PubMed
    Score: 0.011
  126. Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD. Depress Anxiety. 2012 Feb; 29(2):147-54.
    View in: PubMed
    Score: 0.010
  127. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. J Anxiety Disord. 2011 Dec; 25(8):1072-8.
    View in: PubMed
    Score: 0.010
  128. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May; 25(4):536-8.
    View in: PubMed
    Score: 0.010
  129. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
    View in: PubMed
    Score: 0.010
  130. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry. 1991 Jan; 52(1):31-3.
    View in: PubMed
    Score: 0.010
  131. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Soc Sci Med. 2009 Nov; 69(9):1387-94.
    View in: PubMed
    Score: 0.009
  132. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5):447-55.
    View in: PubMed
    Score: 0.009
  133. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. CNS Neurosci Ther. 2009; 15(2):100-6.
    View in: PubMed
    Score: 0.009
  134. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009; 15(3):255-63.
    View in: PubMed
    Score: 0.009
  135. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety. 2009; 26(11):1027-32.
    View in: PubMed
    Score: 0.009
  136. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology. 2009 Jan; 34(2):390-8.
    View in: PubMed
    Score: 0.008
  137. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
    View in: PubMed
    Score: 0.008
  138. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.008
  139. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71.
    View in: PubMed
    Score: 0.008
  140. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95.
    View in: PubMed
    Score: 0.008
  141. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety. 2008; 25(6):496-505.
    View in: PubMed
    Score: 0.008
  142. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cogn Behav Ther. 2008; 37(2):101-16.
    View in: PubMed
    Score: 0.008
  143. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther. 2008; 14(3):165-70.
    View in: PubMed
    Score: 0.008
  144. Complicated grief and impaired sleep in patients with bipolar disorder. Bipolar Disord. 2007 Dec; 9(8):913-7.
    View in: PubMed
    Score: 0.008
  145. Complicated grief: a case series using escitalopram. Am J Psychiatry. 2007 Nov; 164(11):1760-1.
    View in: PubMed
    Score: 0.008
  146. Clonazepam: a review of open clinical trials. J Clin Psychiatry. 1987 Oct; 48 Suppl:12-5.
    View in: PubMed
    Score: 0.008
  147. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76.
    View in: PubMed
    Score: 0.008
  148. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3.
    View in: PubMed
    Score: 0.008
  149. Calcium channel blockers in psychiatry. Psychosomatics. 1987 Jul; 28(7):356-60, 369.
    View in: PubMed
    Score: 0.008
  150. Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82.
    View in: PubMed
    Score: 0.008
  151. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin. 2007 Jun; 23(6):1431-43.
    View in: PubMed
    Score: 0.008
  152. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
    View in: PubMed
    Score: 0.007
  153. Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behav Modif. 2007 Jan; 31(1):32-51.
    View in: PubMed
    Score: 0.007
  154. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis. 2006 Dec; 194(12):962-6.
    View in: PubMed
    Score: 0.007
  155. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
    View in: PubMed
    Score: 0.007
  156. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007 Jan; 97(1-3):91-9.
    View in: PubMed
    Score: 0.007
  157. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
    View in: PubMed
    Score: 0.007
  158. Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord. 2006 Aug; 94(1-3):191-7.
    View in: PubMed
    Score: 0.007
  159. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. J Anxiety Disord. 2007; 21(1):42-58.
    View in: PubMed
    Score: 0.007
  160. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64.
    View in: PubMed
    Score: 0.007
  161. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5.
    View in: PubMed
    Score: 0.007
  162. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 Mar; 63(3):298-304.
    View in: PubMed
    Score: 0.007
  163. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006 Jan; 184(2):139-44.
    View in: PubMed
    Score: 0.007
  164. Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv. 2005 Dec; 56(12):1541-8.
    View in: PubMed
    Score: 0.007
  165. Treatment-emergent incontinence with lithium. J Clin Psychiatry. 1985 Oct; 46(10):444-5.
    View in: PubMed
    Score: 0.007
  166. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005 Sep; 62(9):1022-30.
    View in: PubMed
    Score: 0.007
  167. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10.
    View in: PubMed
    Score: 0.007
  168. Childhood antecedents to panic disorder in referred and nonreferred adults. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):549-61.
    View in: PubMed
    Score: 0.007
  169. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5.
    View in: PubMed
    Score: 0.007
  170. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
    View in: PubMed
    Score: 0.007
  171. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
    Score: 0.007
  172. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depress Anxiety. 2005; 21(2):55-60.
    View in: PubMed
    Score: 0.006
  173. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005; 22(2):47-51.
    View in: PubMed
    Score: 0.006
  174. Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high-risk offspring. Depress Anxiety. 2005; 22(3):114-20.
    View in: PubMed
    Score: 0.006
  175. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
    Score: 0.006
  176. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res. 2004 Sep 15; 131(3):217-26.
    View in: PubMed
    Score: 0.006
  177. Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic. Gen Hosp Psychiatry. 2004 Sep-Oct; 26(5):390-7.
    View in: PubMed
    Score: 0.006
  178. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004 Jul 30; 131(2):135-45.
    View in: PubMed
    Score: 0.006
  179. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl). 2005 Jan; 177(3):280-8.
    View in: PubMed
    Score: 0.006
  180. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9.
    View in: PubMed
    Score: 0.006
  181. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004 Apr; 24(2):141-9.
    View in: PubMed
    Score: 0.006
  182. WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 2003 Aug; 8(8 Suppl 1):40-52.
    View in: PubMed
    Score: 0.006
  183. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
    View in: PubMed
    Score: 0.006
  184. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72.
    View in: PubMed
    Score: 0.006
  185. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.006
  186. Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Res. 2003 Jan 25; 117(1):1-9.
    View in: PubMed
    Score: 0.006
  187. Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11.
    View in: PubMed
    Score: 0.006
  188. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
    View in: PubMed
    Score: 0.005
  189. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98.
    View in: PubMed
    Score: 0.005
  190. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13.
    View in: PubMed
    Score: 0.005
  191. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71.
    View in: PubMed
    Score: 0.005
  192. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000 Aug; 68(4):556-63.
    View in: PubMed
    Score: 0.005
  193. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000 Jul-Aug; 14(4):345-58.
    View in: PubMed
    Score: 0.005
  194. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74.
    View in: PubMed
    Score: 0.005
  195. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000 May; 58(2):99-106.
    View in: PubMed
    Score: 0.005
  196. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depress Anxiety. 2000; 11(1):31-7.
    View in: PubMed
    Score: 0.005
  197. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
    View in: PubMed
    Score: 0.004
  198. Is panic disorder linked to cognitive avoidance of threatening information? J Anxiety Disord. 1999 Jul-Aug; 13(4):335-48.
    View in: PubMed
    Score: 0.004
  199. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Res. 1999 Jun 30; 90(3):143-52.
    View in: PubMed
    Score: 0.004
  200. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60.
    View in: PubMed
    Score: 0.004
  201. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. Br J Psychiatry. 1999 Mar; 174:213-8.
    View in: PubMed
    Score: 0.004
  202. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86.
    View in: PubMed
    Score: 0.004
  203. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998 Nov; 155(11):1570-7.
    View in: PubMed
    Score: 0.004
  204. Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32.
    View in: PubMed
    Score: 0.004
  205. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull. 1998; 34(2):199-205.
    View in: PubMed
    Score: 0.004
  206. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol. 1997 Aug; 17(4):247-54.
    View in: PubMed
    Score: 0.004
  207. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8.
    View in: PubMed
    Score: 0.004
  208. EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62.
    View in: PubMed
    Score: 0.003
  209. Hemispheric laterality and memory bias for threat in anxiety disorders. J Abnorm Psychol. 1994 Nov; 103(4):828-831.
    View in: PubMed
    Score: 0.003
  210. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6.
    View in: PubMed
    Score: 0.003
  211. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biol Psychiatry. 1994 Jul 01; 36(1):57-60.
    View in: PubMed
    Score: 0.003
  212. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
    View in: PubMed
    Score: 0.003
  213. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93.
    View in: PubMed
    Score: 0.003
  214. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
    View in: PubMed
    Score: 0.003
  215. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.003
  216. Focal paroxysmal EEG changes during atypical panic attacks. J Neuropsychiatry Clin Neurosci. 1993; 5(1):50-5.
    View in: PubMed
    Score: 0.003
  217. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33.
    View in: PubMed
    Score: 0.003
  218. Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
    View in: PubMed
    Score: 0.003
  219. Major depression in panic disorder patients with comorbid social phobia. J Affect Disord. 1991 Jul; 22(3):171-7.
    View in: PubMed
    Score: 0.003
  220. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76.
    View in: PubMed
    Score: 0.002
  221. Clonazepam for the treatment of social phobia. J Clin Psychiatry. 1990 Nov; 51(11):470-2.
    View in: PubMed
    Score: 0.002
  222. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
    View in: PubMed
    Score: 0.002
  223. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84.
    View in: PubMed
    Score: 0.002
  224. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7.
    View in: PubMed
    Score: 0.002
  225. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.002
  226. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989 Jun; 28(3):345-50.
    View in: PubMed
    Score: 0.002
  227. Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance. Arch Gen Psychiatry. 1969 Jun; 20(6):652-8.
    View in: PubMed
    Score: 0.002
  228. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122.
    View in: PubMed
    Score: 0.002
  229. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
    View in: PubMed
    Score: 0.002
  230. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
    View in: PubMed
    Score: 0.002
  231. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
    View in: PubMed
    Score: 0.002
  232. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6.
    View in: PubMed
    Score: 0.002
  233. Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9.
    View in: PubMed
    Score: 0.002
  234. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis. 1980 May; 141(5):543-7.
    View in: PubMed
    Score: 0.001
  235. Birth weight and length in schizophrenics personality disorders and their siblings. Br J Psychiatry. 1971 Apr; 118(545):461-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.